Free Trial

ORIC Pharmaceuticals (ORIC) SEC Filings & 10K Form

ORIC Pharmaceuticals logo
$7.68 +0.21 (+2.81%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$7.64 -0.04 (-0.46%)
As of 02/21/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ORIC Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/12/2025
8:30 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:43 PM
Dier Mardi (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:44 PM
Heyman Richard A. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:45 PM
Hoerter Steven L. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:46 PM
Kunkel Lori Anne (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:47 PM
ORIC Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:42 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:21 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:22 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:23 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:31 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:34 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:29 PM
ORIC Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:54 PM
EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
4:47 PM
Nextech Crossover I GP S.a r.l. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
8:42 AM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
08/12/2024
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:10 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:26 PM
ORIC Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:21 PM
Heyman Richard A. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:22 PM
Dier Mardi (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:24 PM
Hoerter Steven L. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:48 PM
Kunkel Lori Anne (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:15 PM
ORIC Pharmaceuticals (Filer)
Form ARS
04/24/2024
3:06 PM
ORIC Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
3:10 PM
ORIC Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
3:47 PM
ORIC Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2024
3:15 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:28 PM
ORIC Pharmaceuticals (Filer)
Form S-3ASR
03/11/2024
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
03/08/2024
3:20 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ORIC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners